FDA Inspection 1164680 — Piedmont Reproductive Endocrinology Associates Lowcountry
The FDA completed an inspection of Piedmont Reproductive Endocrinology Associates Lowcountry on Mar 7, 2022 in Summerville, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 7, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Summerville, SC (United States)